Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cinta M. Papke
Observed name:
Cinta Maria Papke
Institution:
University of South Alabama
Observed institution:
University of South Alabama
ORCID:
0000-0003-0719-2642
Observed ORCID:
0000-0003-0719-2642
OpenAlex ID:
A5081929089
The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C
2019
·
Brandon M. D'Arcy
, Mark R. Swingle
, et al.
·
Molecular Cancer Therapeutics
·
81
A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth
2021
·
Cinta M. Papke
, Kali A. Smolen
, et al.
·
Journal of Biological Chemistry
·
37
Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades
2023
·
Kali A. Smolen
, Cinta M. Papke
, et al.
·
Journal of Biological Chemistry
·
21
PDF
Thymineless Death by the Fluoropyrimidine Polymer F10 Involves Replication Fork Collapse and Is Enhanced by Chk1 Inhibition
2018
·
Chinnadurai Mani
, Sachin Pai
, et al.
·
Neoplasia
·
19
PDF
Data from The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C
2023
·
Brandon M. D'Arcy
, Mark R. Swingle
, et al.
Supplementary Methods, Supplementary Table S1, and Supplementary Figures S1-S2 from The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C
2023
·
Brandon M. D'Arcy
, Mark R. Swingle
, et al.
Show more works
View as search
Works count:
6
Citation count:
158
H-index:
4
I10-index:
4
Year
Topic
Type